Endocrine Centre, Austin Health, Heidelberg Repatriation Hospital Campus, Heidelberg West, Victoria 3081, Australia.
Metabolism. 2012 Jun;61(6):873-82. doi: 10.1016/j.metabol.2011.10.017. Epub 2011 Dec 5.
The objective was to compare weight loss and change in body composition in obese subjects with and without type 2 diabetes mellitus during a very-low-calorie diet (VLCD) program. Seventy weight-matched subjects with diabetes or normal fasting glucose (controls) participated in a 24-week VLCD study. Primary end points were changes in anthropometry, body composition, and fasting plasma insulin and β-hydroxybutyrate concentrations. Fifty-one subjects (24 with diabetes) completed the study. No difference in weight loss between the 2 groups at 24 weeks was found by intention-to-treat analysis. Both groups completing the study per protocol had near-identical weight change during the program, with similar weight loss at 24 weeks (diabetes: 8.5 ± 1.3 kg vs control: 9.4 ± 1.2 kg, P = .64). Change in fat mass index correlated with change in body mass index (BMI) in both groups (diabetes: r = 0.878, control: r = 0.920, both P < .001); but change in fat mass index per unit change in BMI was less in the diabetic group compared with controls (0.574 vs 0.905 decrease, P = .003), which persisted after adjusting for age, sex, and baseline BMI (P = .008). Insulin concentrations remained higher and peak β-hydroxybutyrate concentrations were lower in the diabetic compared with the control group. While following a 24-week VLCD program, obese subjects with and without diabetes achieved comparable weight loss; but the decrease in adiposity per unit weight loss was attenuated in diabetic subjects. Hyperinsulinemia may have inhibited lipolysis in the diabetic group; however, further investigation into other factors is needed.
目的是比较肥胖伴有和不伴有 2 型糖尿病的患者在极低热量饮食(VLCD)方案中减肥和身体成分变化的情况。70 名体重匹配的糖尿病或空腹血糖正常(对照组)患者参加了一项 24 周的 VLCD 研究。主要终点是人体测量学、身体成分以及空腹血浆胰岛素和β-羟丁酸浓度的变化。51 名患者(24 名糖尿病患者)完成了研究。意向治疗分析显示,两组在 24 周时的体重减轻没有差异。根据方案完成研究的两组在研究期间体重变化几乎相同,24 周时体重减轻相似(糖尿病组:8.5 ± 1.3 kg vs 对照组:9.4 ± 1.2 kg,P =.64)。脂肪量指数的变化与两组的体重指数(BMI)变化相关(糖尿病组:r = 0.878,对照组:r = 0.920,均 P <.001);但是,糖尿病组每单位 BMI 变化的脂肪量指数变化小于对照组(0.574 与 0.905 减少,P =.003),在调整年龄、性别和基线 BMI 后仍然存在(P =.008)。胰岛素浓度在糖尿病组中仍然较高,峰值β-羟丁酸浓度较低。在遵循 24 周 VLCD 方案时,肥胖伴有和不伴有糖尿病的患者均能达到相当的体重减轻;但是,糖尿病患者的脂肪减少量每单位体重减轻量减少。高胰岛素血症可能抑制了糖尿病组的脂肪分解;然而,需要进一步研究其他因素。